title: Ocular Immune Privilege and Transplantation.
abstract: Allografts are afforded a level of protection from rejection within immune-privileged tissues. Immune-privileged tissues involve mechanisms that suppress inflammation and promote immune tolerance. There are anatomical features, soluble factors, membrane-associated proteins, and alternative antigen-presenting cells (APC) that contribute to allograft survival in the immune-privileged tissue. This review presents the current understanding of how the mechanism of ocular immune privilege promotes tolerogenic activity by APC, and T cells in response to the placement of foreign antigen within the ocular microenvironment. Discussed will be the unique anatomical, cellular, and molecular mechanisms that lessen the chance for graft destroying immune responses within the eye. As more is understood about the molecular mechanisms of ocular immune privilege greater is the potential for using these molecular mechanisms in therapies to prevent allograft rejection.
authors.affiliation: Department of Ophthalmology, Boston University School of Medicine , Boston, MA , USA.
authors.forename: Andrew W
authors.initials: AW
authors.lastname: Taylor
keywords: anterior chamber-associated immune deviation; immune privilege; immune tolerance; regulatory T cells